Leading banks back Oxford Nanopore after London Calling showcases maturing platform

Oxford Nanopore Technologies PLC (LSE:ONT), the LSE-listed DNA sequencing company, has drawn positive reviews from RBC Capital Markets and Citi following its annual London Calling customer conference last week, with both brokers reiterating buy-equivalent ratings on the stock. RBC Capital Markets carries an outperform rating and 225p target price, while Citi rates the shares buy with a high-risk designation, noting that Oxford Nanopore trades on just 2.3 times estimated 2027 enterprise value to sales, which it considers compelling given the company's growth profile.